Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

BioScience Health Innovations (BHIC) Gross Profit (2023 - 2025)

BioScience Health Innovations (BHIC) has disclosed Gross Profit for 3 consecutive years, with $571863.0 as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 68.69% to $571863.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2025, up 147.59% year-over-year, with the annual reading at $3.2 million for FY2025, 147.59% up from the prior year.
  • Gross Profit for Q4 2025 was $571863.0 at BioScience Health Innovations, down from $698231.0 in the prior quarter.
  • The five-year high for Gross Profit was $1.1 million in Q2 2025, with the low at $27591.0 in Q1 2023.
  • Average Gross Profit over 3 years is $419501.0, with a median of $324692.5 recorded in 2024.
  • Peak annual rise in Gross Profit hit 750.87% in 2024, while the deepest fall reached 43.34% in 2024.
  • Over 3 years, Gross Profit stood at $236511.0 in 2023, then skyrocketed by 43.34% to $339009.0 in 2024, then surged by 68.69% to $571863.0 in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $571863.0, $698231.0, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.